Claire Birrell

Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study

Christopher E. Brightling, Eugene R. Bleecker, Reynold A. Panettieri et al. · The Lancet Respiratory Medicine · 2014 · 306 citations · Full text

Advanced Lung Disease, Immunology, Clinical Trials +7

Desensitization of the nicotine‐induced mesolimbic dopamine responses during constant infusion with nicotine

Maureen E.M. Benwell, David J.K. Balfour, Claire Birrell · British Journal of Pharmacology · 1995 · 168 citations · Full text

Psychopharmacology, Locomotor Activity, Pharmacotherapy +23

Factor structure and external validity of the PANSS revisited

Edwin J. C. G. van den Oord, Dan Rujescu, Jaime R. Robles et al. · Schizophrenia Research · 2005 · 151 citations

Social Identity, Psychosocial Determinant, Social Cognition +3

An open‐label, single‐dose bioavailability study of the pharmacokinetics of CAT‐354 after subcutaneous and intravenous administration in healthy males

Chad K. Oh, Raffaella Faggioni, Feng Jin et al. · British Journal of Clinical Pharmacology · 2010 · 62 citations · Full text

The influence of nicotine pretreatment on mesoaccumbens dopamine overflow and locomotor responses to D -amphetamine

Claire Birrell, D. J. K. Balfour · Psychopharmacology · 1998 · 53 citations

Locomotor Responses, Psychoactive Drug, Behavioral Neuroscience +13